These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15469888)

  • 41. Stimulatory and Inhibitory Effect of Antipsychotic Agents Including Dopaminergic Neuro-depressants on Dopamine Formation from
    Niwa T; Yamamoto Y
    Drug Metab Bioanal Lett; 2024; 17(1):1-6. PubMed ID: 37711131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional and structural characterisation of common cytochrome P450 2D6 allelic variants-roles of Pro34 and Thr107 in catalysis and inhibition.
    Dong AN; Ahemad N; Pan Y; Palanisamy UD; Yiap BC; Ong CE
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):1015-1029. PubMed ID: 31025144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns.
    Schwarz D; Kisselev P; Chernogolov A; Schunck WH; Roots I
    Biochem Biophys Res Commun; 2005 Oct; 336(3):779-83. PubMed ID: 16153604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles.
    Bogni A; Monshouwer M; Moscone A; Hidestrand M; Ingelman-Sundberg M; Hartung T; Coecke S
    Toxicol In Vitro; 2005 Aug; 19(5):621-9. PubMed ID: 15893449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of dimethyl sulfoxide on the function of cytochrome P450 2D6 in HepG2 cells upon the co-expression with NADPH-cytochrome P450 reductase.
    Narimatsu S; Takatsu N; Yamano S; Inoue Y; Hanioka N; Kiryu K; Naito S; Gonzalez FJ; Yamamoto S
    Chem Biol Interact; 2006 Jan; 159(1):47-57. PubMed ID: 16214121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling.
    Zhu W; Mantione KJ; Shen L; Cadet P; Esch T; Goumon Y; Bianchi E; Sonetti D; Stefano GB
    Med Sci Monit; 2005 Nov; 11(11):BR397-404. PubMed ID: 16258388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function.
    Oscarson M; Hidestrand M; Johansson I; Ingelman-Sundberg M
    Mol Pharmacol; 1997 Dec; 52(6):1034-40. PubMed ID: 9415713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris.
    Dietrich M; Grundmann L; Kurr K; Valinotto L; Saussele T; Schmid RD; Lange S
    Chembiochem; 2005 Nov; 6(11):2014-22. PubMed ID: 16222729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
    Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
    Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic polymorphism of CYP2D6 in patients with cardiovascular disease -- a cohort study.
    Teh LK; Zilfalil BA; Marina I; Rosemi BS; Ismail R
    J Clin Pharm Ther; 2004 Dec; 29(6):559-64. PubMed ID: 15584944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Propranolol hydroxylation and N-desisopropylation by cytochrome P4502D6: studies using the yeast-expressed enzyme and NADPH/O2 and cumene hydroperoxide-supported reactions.
    Bichara N; Ching MS; Blake CL; Ghabrial H; Smallwood RA
    Drug Metab Dispos; 1996 Jan; 24(1):112-8. PubMed ID: 8825198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms.
    van der Padt A; van Schaik RH; Sonneveld P
    Neth J Med; 2006 May; 64(5):160-2. PubMed ID: 16702617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional characterization of wild-type and 49 CYP2D6 allelic variants for N-desmethyltamoxifen 4-hydroxylation activity.
    Muroi Y; Saito T; Takahashi M; Sakuyama K; Niinuma Y; Ito M; Tsukada C; Ohta K; Endo Y; Oda A; Hirasawa N; Hiratsuka M
    Drug Metab Pharmacokinet; 2014; 29(5):360-6. PubMed ID: 24647041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
    Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
    Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-dopamine crosstalk revisited.
    Ozdemir V; Bertilsson L; Miura J; Carpenter E; Reist C; Harper P; Widén J; Svensson JO; Albers LJ; Kennedy JL; Endrenyi L; Kalow W
    Pharmacogenet Genomics; 2007 May; 17(5):339-47. PubMed ID: 17429316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substrate-dependent functional alterations of seven CYP2C9 variants found in Japanese subjects.
    Maekawa K; Harakawa N; Sugiyama E; Tohkin M; Kim SR; Kaniwa N; Katori N; Hasegawa R; Yasuda K; Kamide K; Miyata T; Saito Y; Sawada J
    Drug Metab Dispos; 2009 Sep; 37(9):1895-903. PubMed ID: 19541829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Catalytic roles of CYP2D6.10 and CYP2D6.36 enzymes in mexiletine metabolism: in vitro functional analysis of recombinant proteins expressed in Saccharomyces cerevisiae.
    Hanioka N; Okumura Y; Saito Y; Hichiya H; Soyama A; Saito K; Ueno K; Sawada J; Narimatsu S
    Biochem Pharmacol; 2006 Apr; 71(9):1386-95. PubMed ID: 16527257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
    Fux R; Mörike K; Pröhmer AM; Delabar U; Schwab M; Schaeffeler E; Lorenz G; Gleiter CH; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2005 Oct; 78(4):378-87. PubMed ID: 16198657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inactivation of CYP2D6 by methylenedioxymethamphetamine in different recombinant expression systems.
    Van LM; Hargreaves JA; Lennard MS; Tucker GT; Rostami-Hodjegan A
    Eur J Pharm Sci; 2007 Sep; 32(1):8-16. PubMed ID: 17574396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary bioactivation of trichloroethylene to chloral hydrate: relative contributions of CYP2E1, CYP2F, and CYP2B1.
    Forkert PG; Baldwin RM; Millen B; Lash LH; Putt DA; Shultz MA; Collins KS
    Drug Metab Dispos; 2005 Oct; 33(10):1429-37. PubMed ID: 15987776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.